This filing signals extreme financial distress and massive dilution. The company has no U.S. approved products, is burning cash rapidly, and faces Nasdaq delisting. The ELOC structure (97% of VWAP) and convertible notes with aggressive conversion terms create a toxic financing dynamic. Monitor the Nasdaq hearing outcome and any FDA regulatory milestones for Lumee Oxygen/Glucose. Avoid long positions until the company demonstrates a credible path to revenue and compliance.
Executive Summary
Profusa, Inc. filed an S-1 registration statement to register up to 179,272,293 shares of common stock for resale by selling stockholders, primarily Ascent Partners Fund LLC. The filing covers shares issuable under an ELOC purchase agreement (up to $100M capacity), convertible notes, and warrants. The company has a going concern qualification, massive net losses ($35.8M in 2025), and is facing Nasdaq delisting, making this a highly dilutive and distressed capital raise.
Key Facts
- Registers up to 179,272,293 shares for resale, representing ~97.2% dilution vs. 4,410,268 shares outstanding as of April 24, 2026.
- Net loss of $35.8 million for FY2025 vs $9.2 million in FY2024; accumulated deficit of $160.8 million.
- Auditors include going concern qualification; cash balance only $1.8 million as of Dec 31, 2025.
- Received Nasdaq delisting determination on March 11, 2026 for failure to meet minimum bid price and MVLS requirements; appeal hearing held April 21, 2026, no final decision yet.
- ELOC with Ascent allows sale of up to $100M of stock at 97% of VWAP; $10.3M drawn through Dec 31, 2025; additional $89.7M capacity remaining.
- Ascent convertible notes total $13.9M principal; bear 10%-12% interest; convertible at 95% of lowest 10-day VWAP.
- Revenue was $0 in 2025 vs $100K in 2024; no products approved for sale in the U.S.
Financial Impact
Up to $100M in potential gross proceeds from ELOC, but at massive dilution (150.6M new shares registered). Existing shareholders face ~97% dilution if fully drawn. Net loss of $35.8M in 2025.
Risk Factors
- Nasdaq delisting likely; stock could trade OTC, severely limiting liquidity and access to capital.
- Massive dilution from ELOC and convertible note conversions; 150.6M new shares registered vs 4.4M outstanding.
- Going concern risk; only $1.8M cash as of Dec 31, 2025 with $22.3M in current liabilities.
- No FDA-approved products in the U.S.; regulatory pathway uncertain and costly.
- Ascent holds significant leverage with convertible notes at 95% of VWAP and ELOC at 97% of VWAP, creating downward price pressure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1 Filing (Primary) | 0001213900-26-048288 |
| Document: ea028708601ex-fee.htm | 0001213900-26-048288 |
| Document: ea028708601ex5-1.htm | 0001213900-26-048288 |
| Document: ea028708601ex23-1.htm | 0001213900-26-048288 |
| Document: ea028708601ex23-2.htm | 0001213900-26-048288 |
| Document: 0001213900-26-048288-index-headers.html | 0001213900-26-048288 |
| Document: 0001213900-26-048288-index.html | 0001213900-26-048288 |
| Document: 0001213900-26-048288.txt | 0001213900-26-048288 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 8, 2026 20w ago | 8-K | — | awaiting T+20 | — | — |
May 26, 2026 21w ago | 8-K | — | awaiting T+20 | — | — |
May 15, 2026 23w ago | 8-K | — | awaiting T+20 | — | — |
May 8, 2026 24w ago | 8-K | — | awaiting T+20 | — | — |
May 1, 2026 25w ago | S-1/A | — | awaiting T+20 | — | — |
Apr 29, 2026 25w ago | 8-K | — | awaiting T+20 | — | — |
Apr 28, 2026 25w ago | S-1 | — | awaiting T+20 | — | — |
Apr 27, 2026 26w ago | 8-K | — | awaiting T+20 | — | — |
Apr 24, 2026 26w ago | 8-K | — | awaiting T+20 | — | — |
Apr 6, 2026 29w ago | 8-K | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers